Business Wire (Thu, 2:13PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
150 people get CHE articles and Market Currents by email alert.
Get email alerts on CHE »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Mon, 1:58PM)
-
Business Wire (May 14, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 21, 2013)
-
Business Wire (Feb 18, 2013)
-
Business Wire (Jan 31, 2013)
-
-
-
Business Wire (Jan 22, 2013)
-
Business Wire (Jan 2, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
Chemed Urges Stockholders to Ignore Millbrook CapitalTodd Walker • Mon, May 18, 2009 -
-
Chemed Corporation Showing Strong GrowthZacks Investment Research • Fri, Nov 28, 2008 -
-
Chemed Corp.: Major Player in Hospice and PlumbingZacks Investment Research • Mon, Feb 26, 2007
-
-
-
-
-
-
-
-
-
15 Small-Cap Rockets In An Unexpected SectorKurtis Hemmerling • Sun, Dec 11, 2011 -
-
-
4 Healthcare Dividend Stocks With Impressive ProfitabilityKapitall • Mon, Sep 19, 2011
-
5 Healthcare Dividend Stocks Being Bought By Smart MoneyKapitall • Wed, Sep 7, 2011
-
-
-
-
-
-
-
-
Chemed Corporation Q4 2008 Earnings Call TranscriptTue, Feb 17, 2009
-
Chemed Corporation, Q3 2008 Earnings Call TranscriptWed, Oct 22, 2008
-
Chemed Corporation Q2 2008 Earnings Call TranscriptTue, Jul 29, 2008
-
CHEMED Corporation Q1 2008 Earnings Call TranscriptMon, May 19, 2008
-
Chemed Corporation Q4 2007 Earnings Call TranscriptFri, Feb 22, 2008
-
Business Wire (Thu, 2:13PM)
-
Business Wire (Mon, 1:58PM)
-
Business Wire (May 14, 2013)
-
Business Wire (May 6, 2013)
-
at MarketWatch.com (May 3, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 21, 2013)
-
Business Wire (Feb 18, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 22, 2013)
-
Business Wire (Jan 2, 2013)
-
Business Wire (Dec 6, 2012)
-
Business Wire (Nov 9, 2012)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Oct 29, 2012)
-
Business Wire (Oct 10, 2012)
CHE vs. ETF Alternatives
Company Description
Currently, there's no company description for CHE.
-
- View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/10wM90I Link to US Justice Dept release charging Chemed and its Vitas Hospice subsidiary for medicare fraud $CHE - View all 8 replies
-
valueinvestor20: Don't think there will be material compliance cost. Some pullback in continuous care business - maybe a 5% hit to earnings. -
valueinvestor20: I would guess settlement is ultimately <$100mm which should not be an issue - company has unlevered balance sheet and is cash generative.
-
Andrew Shapiro
http://on.wsj.com/1008hEQ U.S. Sues Chemed for Vitas' False Medicare Billings Costing 'Tens of Millions of Taxpayer $CHE - View all 0 replies
-
Daniel Long
2 stocks hitting 10 yr highs in our most Undervalued Ind-Home Health Care, in most Overvalued Sec-Healthcare $ADUS $CHE http://bit.ly/Xxbb1g - View all 0 replies
-
- View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/ODEh9T Do #Chemed's #Hospice regulatory subpoenas infer additional risk for #Gentiva's Hospice operations? $CHE $GTIV - View all 0 replies
-
Andrew Shapiro
Do Chemed's VITAS Hospice regulatory subpoenas infer additional risk for Gentiva's Hospice operations? $CHE $GTIV - View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/ODEh9T Chemed 10-CTL regulatory matters - separate July 2012 FLA subpoena for info from 01/2007 too $CHE #hospice - View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/ODEh9T Chemed 10-CTL - regulatory matters - subpoena from OIG for info from 01/2007 to 6/2012 period $CHE #hospice - View all 0 replies
-
Andrew Shapiro
Chemed 10-CTL released with updated regulatory matters language; issued subpoena from OIG for info from 01/2007 to 6/2012 period $CHE - View all 0 replies
LATEST REPLIES
-
Andrew Shapiro
http://1.usa.gov/10wM90I Link to US Justice Dept release charging Chemed and its Vitas Hospice subsidiary for medicare fraud $CHE - View all 8 replies
-
valueinvestor20: Don't think there will be material compliance cost. Some pullback in continuous care business - maybe a 5% hit to earnings.
-
valueinvestor20: I would guess settlement is ultimately <$100mm which should not be an issue - company has unlevered balance sheet and is cash generative.